Page last updated: 2024-11-07

2-acetylaminofluorene and Arteriosclerosis

2-acetylaminofluorene has been researched along with Arteriosclerosis in 2 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izzotti, A1
D'Agostini, F1
Bagnasco, M1
Scatolini, L1
Rovida, A1
Balansky, RM1
Cesarone, CF1
De Flora, S1
Penn, A1
Snyder, C1

Reviews

1 review available for 2-acetylaminofluorene and Arteriosclerosis

ArticleYear
Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases.
    Cancer research, 1994, Apr-01, Volume: 54, Issue:7 Suppl

    Topics: 2-Acetylaminofluorene; Acetylcysteine; Animals; Anticarcinogenic Agents; Aorta, Abdominal; Arteriosc

1994

Other Studies

1 other study available for 2-acetylaminofluorene and Arteriosclerosis

ArticleYear
Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons.
    Carcinogenesis, 1988, Volume: 9, Issue:12

    Topics: 2-Acetylaminofluorene; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthracenes; Arteriosclerosis; Ben

1988